U.S. flag

An official website of the United States government

NM_005732.4(RAD50):c.12_13delinsTT (p.Glu5Ter) AND Hereditary cancer-predisposing syndrome

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Feb 14, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002347192.2

Allele description [Variation Report for NM_005732.4(RAD50):c.12_13delinsTT (p.Glu5Ter)]

NM_005732.4(RAD50):c.12_13delinsTT (p.Glu5Ter)

Gene:
RAD50:RAD50 double strand break repair protein [Gene - OMIM - HGNC]
Variant type:
Indel
Cytogenetic location:
5q31.1
Genomic location:
Preferred name:
NM_005732.4(RAD50):c.12_13delinsTT (p.Glu5Ter)
HGVS:
  • NC_000005.10:g.132557336_132557337delinsTT
  • NG_021151.2:g.5360_5361delinsTT
  • NG_105751.1:g.837_838delinsTT
  • NM_005732.4:c.12_13delinsTTMANE SELECT
  • NP_005723.2:p.Glu5Ter
  • LRG_312t1:c.12_13delinsTT
  • LRG_312:g.5360_5361delinsTT
  • LRG_312p1:p.Glu5Ter
  • NC_000005.9:g.131893028_131893029delinsTT
  • NM_005732.3:c.12_13delCGinsTT
Protein change:
E5*
Molecular consequence:
  • NM_005732.4:c.12_13delinsTT - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002644743Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Likely pathogenic
(Feb 14, 2020)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Ambry Genetics, SCV002644743.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The c.12_13delCGinsTT variant, located in coding exon 1 of the RAD50 gene, results from an in-frame deletion of CG and insertion of TT at nucleotide positions 12 to 13. This changes the amino acid at codon 5 from a glutamic acid to a stop codon. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. However, the RAD50 gene contains a second methionine encoding an initiation sequence 21 nucleotides (seven amino acids) downstream of the canonical start site. This has the potential to function as an alternate translation initiation site, resulting in the removal of the first six amino acids from the protein; however, direct evidence is unavailable. Other variants that impact the p.M1 initiation codon, p.M1? (c.1A>G) and p.M1? (c.3G>A), are expected to result in either loss of translation initiation, N-terminal truncation, or cause a shift in the mRNA reading frame, and are interpreted as likely pathogenic. Based on the majority of available evidence to date, this variant is likely to be pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024